Blockade of vasopressin V1b receptor displays anxiolytic and antidepressant effects in animal models

被引：0
|
作者：
Shimazaki, Toshiharu [1 ]
Iijima, Michihiko [1 ]
Ito, Akie [1 ]
Chaki, Shigeyuki [1 ]
机构：
[1] Taisho Pharmaceut Co Ltd, Med Res Labs, Kitaku, Saitama, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2007年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：233P / 233P
页数：1
相关论文
共 50 条
  • [21] Evidence that atypical vasopressin V2 receptor in inner medulla of kidney is V1B receptor
    Saito, M
    Tahara, A
    Sugimoto, T
    Abe, K
    Furuichi, K
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (03) : 289 - 296
  • [22] Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders
    Griebel, G
    Simiand, J
    Gal, CSL
    Wagnon, J
    Pascal, M
    Scatton, B
    Maffrand, JP
    Soubrié, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) : 6370 - 6375
  • [23] Altered lipid metabolism in vasopressin V1B receptor-deficient mice
    Hiroyama, Masami
    Fujiwara, Yoko
    Nakamura, Kazuaki
    Aoyagi, Toshinori
    Mizutani, Reiko
    Sanbe, Atsushi
    Tasaki, Ryuji
    Tanoue, Akito
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 602 (2-3) : 455 - 461
  • [24] Vasopressin V1b receptor knockout reduces aggressive behavior in male mice
    Wersinger, SR
    Ginns, EI
    O'Carrol, AM
    Lolait, SJ
    Young, WS
    MOLECULAR PSYCHIATRY, 2002, 7 (09) : 975 - 984
  • [25] Characterization of a functional V1B vasopressin receptor in the male rat kidne evidence for cross talk between V1B and V2 receptor signaling pathways
    Hus-Citharel, Annette
    Bouby, Nadine
    Corbani, Maithe
    Mion, Julie
    Mendre, Christiane
    Darusi, Judit
    Tomboly, Csaba
    Trueba, Miguel
    Serradeil-Le Gal, Claudine
    Llorens-Cortes, Catherine
    Guillon, Gilles
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 321 (03) : F305 - F321
  • [26] Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand
    Serradeil-Le Gal, Claudine
    Raufaste, Daniele
    Derick, Sylvain
    Blankenstein, Joerg
    Allen, John
    Pouzet, Brigitte
    Pascal, Marc
    Wagnon, Jean
    Ventura, Maria Angeles
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2007, 293 (02) : R938 - R949
  • [27] Vasopressin V1b receptor knockout reduces aggressive behavior in male mice
    S R Wersinger
    E I Ginns
    A-M O'Carroll
    S J Lolait
    W S Young III
    Molecular Psychiatry, 2002, 7 : 975 - 984
  • [28] The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders
    Griebel, Guy
    Simiand, Jacques
    Stemmelin, Jeanne
    Serradeil-Le Gal, Claudine
    Steinberg, Regis
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (03) : 191 - 200
  • [29] The magnocellular vasopressin neurones of the rat hypothalamus express V1a and V1b but not V2 vasopressin receptor mRNAs
    Hurbin, A
    Boissin-Agasse, L
    Orcel, H
    Rabié, A
    Joux, N
    Desarménien, MG
    Richard, P
    Moos, FC
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 509P : 87P - 87P
  • [30] Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists
    Baker, James
    Bingham, Matilda
    Blackburn-Munro, Ruth
    Cai, Jiaqiang
    Craighead, Mark
    Gilfillan, Robert
    Goan, Kate
    Jaap, David
    Milne, Rachel
    Morphy, J. Richard
    Napier, Susan
    Presland, Jeremy
    Spinks, Gayle
    Thomson, Fiona
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3603 - 3607
12345